Page last updated: 2024-10-22

albuterol and Embolism, Pulmonary

albuterol has been researched along with Embolism, Pulmonary in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daly, MJ1

Other Studies

1 other study available for albuterol and Embolism, Pulmonary

ArticleYear
Pulmonary mechanical effects of experimental lung embolism and their modification by bronchodilator drugs in the guinea-pig.
    British journal of pharmacology, 1974, Volume: 51, Issue:4

    Topics: Albuterol; Aminophylline; Animals; Barium; Bronchodilator Agents; Guinea Pigs; In Vitro Techniques;

1974